Board of Gufic BioSciences approves change in directorate

The share has touched a 52-week high of Rs 245.

Gufic Biosciences hits 52-week high China nod to anaesthesia API

Buzzing stocks: Kalyan Jewellers, Piramal Pharma, ABB, Dr Reddy’s Lab, Nexus Select Trust, Gufic Biosciences, Wipro, Ram Ratna Wire, HDFC Bank, Axiscades Technologies, Suraj, Skipper

Stocks that will see action today: June 19, 2023

Gufic said one of the important feature of ’Zarbot is that it has been manufactured using purified HALL strain and proprietary technology which results in thin film formulation and better stability compared to other botulinum toxin brands.

Gufic Biosciences launches locally made botox injection

An upcoming facility in Indore will cater to domestic and global markets

Gufic Biosciences to invest ₹240 crore in new units

Contributing immensely to the government’s ambitious Make in India drive, Gufic has collaborated with its European counterpart to manufacture this new technology indigenously in India. Until now the dual chamber bags have been largely imported in

Gufic Biosciences launches indigenously produced Dual Chamber Bags

Rating agency CRISIL Ratings has revised the company’s outlook on the long-term bank facilities

Gufic Biosciences soars 14%, hits 52-week high on improved business outlook

Gufic Biosciences rose 1.58% to Rs 263.05 after the company received the DCGI approval for Thymosin Alpha-1 (Immunocin α) as an add-on therapy for the treatment of moderate-to-severe COVID-19 patients requiring ventilator support.

Gufic Biosciences gains on DCGA nod for Thymosin Alpha-1

Buzzing stocks: Tata Steel, TCS, Tata Power, TVS Motor, Marico, U Gro Capital, Sejal Glass, Gufic Biosciences, Rain Industries, PSP Projects and Coastal Corp

Stocks that will see action today

Gufic Biosciences incorporates wholly-owned subsidiary in UK

Stocks In the News: Check out the companies making headlines before the opening bell.

Buzzing Stocks | BEML, Gufic Biosciences, Satin Creditcare Network, others in news today

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Average profitability - not good, not bad

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Gufic Biosciences Limited manufactures pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Formulations, Bulk Drugs and Consumer.